Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130844 · ClinicalTrials.gov registry record · Phase 1
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT01130844 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 52 participants.
The verdict
NCT01130844, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and pharmacokinetics of MMX mesalamine following administration in children and adolescents with ulcerative colitis.
Interventions
- DRUG MMX Mesalamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2010-10-08 |
| Est. Completion | 2013-06-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01130844
The ClinicalTrials.gov registry entry for NCT01130844 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MMX Mesalamine is the first listed.
NCT01130844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01130844 about?
NCT01130844 is a clinical study titled "Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis". The purpose of this study is to determine the safety and pharmacokinetics of MMX mesalamine following administration in children and adolescents with ulcerative colitis.
What is the current status of trial NCT01130844?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2010-10-08. Estimated completion is 2013-06-27.
What interventions are being tested in trial NCT01130844?
The interventions under investigation include: MMX Mesalamine (DRUG).
Who is sponsoring clinical trial NCT01130844?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.